RNAi Therapeutics Market adoption in North America is encouraged by clinical research activity, specialized RNA manufacturing capabilities, and advances in targeted drug delivery. The RNAi Therapeutics Market was valued at US$ 1.5 billion in 2021 and is projected to reach US$ 3.2 billion by 2031, registering a CAGR of 16.5% during the forecast period from 2023 to 2031. Market growth is...